InnoStar

InnoStar has the industry-leading international service capability and provides one-stop new drug research and development services that are compliant with domestic and international application standards for global pharmaceutical companies and research institutions. After years of development, InnoStar now has built up nearly 60,000 square meters of modern laboratory and test facilities, employing over one thousand scientists and professional technicians in Shanghai, Nantong, Shenzhen, Huangshan, and USA. 1. Relevant Qualification Over the past decade, InnoStar has successfully passed GLP inspections by various national and international authorities, including US FDA, and received the GLP certification form the National Medical Products Administration (NMPA),...

Pharmacodynamics,pharmacokinetics,cro,new drug r&d,druggability assessment,nonclinical assessment,safety evaluation,new drug registration,small molecules,adc,peptide drugs,protac,antibody drugs,molecular glues,therapeutic vaccines,cell and gene therapeutics,and prophylactic vaccine

Innostar operates in the Pharmaceutical manufacturing industry.

Innostar's revenue is 11m - 100m

Innostar has 11 - 50 employees.